Abstract:Background Cervical cancer patients have a high risk of metastasis and a poor prognosis with shorter disease-free survival. Thus, novel biomarkers and feasible therapies urgently need to be discovered. Previous studies have shown that miR-95-3p plays crucial roles in several cancer types. However, the roles of miR-95-3p in cervical cancer remain unknown. Methods The micro ribonucleic acid (miRNA) expression data and clinical characteristics of cervical cancer samples were downloaded from The Cancer Genome Atlas (TCGA) database. Univariate and multivariate Cox regression analyses were conducted to identify the prognostic-related miRNAs. The potential target genes of miR-95-3p were predicted by the TargetScan database. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses were conducted to explore the target gene of miR-95-3p. The effects of miR-95-3p inhibition and overexpression on cell proliferation were inspected by cell counting kit-8 (CCK-8) assays and cell colony formation assays. Wound-healing assays and transwell assays were also used to examine cell migration ability in HeLa and SiHa cells. Results MiR-95-3p was the only miRNA significantly associated with the poor prognosis of cervical squamous cell carcinoma. A further analysis suggested that vascular cell adhesion molecule 1 (VCAM1) is a target gene of miR-95-3p in cervical cancer, and miR-95-3p promotes the malignant behavior of cervical cancer cells by inhibiting the expression of VCAM1. The CCK-8 and cell colony assays showed that miR-95-3p downregulation significantly suppressed cell proliferation in the HeLa and SiHa cells. The transwell and wound-healing assays showed that miR-95-3p inhibition suppressed cell migration in the HeLa and SiHa cells. Further the Western blot analysis and the quantitative real-time-polymerase chain reaction (qRT-PCR) showed that the knockdown of miR-95-3p in HeLa cells resulted in increased VCAM1 expression. And VCAM1 was highly expressed in the paired adjacent normal cervical epithelium tissue samples, but lowly expressed in the cervical tumor tissue samples. Conclusions Our study was the first to show that miR-95-3p could serve as a prognostic biomarker of cervical cancer. Mechanistically, we discovered that miR-95-3p inhibited the expression of the cell adhesion molecule VCAM1 and thus promoted further tumor progression.

Aberrant Expression of Mir-153 is Associated with the Poor Prognosis of Cervical Cancer

Downregulation of Mir-138 Predicts Poor Prognosis in Patients with Esophageal Squamous Cell Carcinoma.

Mir-130A-3p Promotes Cell Proliferation and Invasion by Targeting Estrogen Receptor Α and Androgen Receptor in Cervical Cancer.

Suppressed Mir-424 Expression Via Upregulation of Target Gene Chk1 Contributes to the Progression of Cervical Cancer

Mir-182 Induces Cervical Cancer Cell Apoptosis Through Inhibiting the Expression of DNMT3a.

MicroRNA-140-5p Targets Insulin Like Growth Factor 2 Mrna Binding Protein 1 (IGF2BP1) to Suppress Cervical Cancer Growth and Metastasis.

Dysregulated microRNAs involved in the progression of cervical neoplasm

MiR-95-3p Acts As a Prognostic Marker and Promotes Cervical Cancer Progression by Targeting VCAM1

MicroRNA-152 Acts As a Tumor Suppressor MicroRNA by Inhibiting Krüppel-Like Factor 5 in Human Cervical Cancer.

Aberrant expression of microRNAs in gastric cancer and biological significance of miR-574-3p

Aberrant Expression of miR-203 and Its Clinical Significance in Gastric and Colorectal Cancers

MiRNA-873-5p Acts as a Potential Novel Biomarker and Promotes Cervical Cancer Progression by Regulating ZEB1 via Notch Signaling Pathway

Mir-203a-5p Suppresses Cervical Cancer Cell Tumorigenesis And Emt Via Targeting Mapk1

Aberrant Expression of Oncogenic and Tumor-Suppressive Micrornas in Cervical Cancer is Required for Cancer Cell Growth

Downregulation of Mir-193A-3p is Involved in the Pathogenesis of Hepatocellular Carcinoma by Targeting CCND1

Bioinformatics analysis illustrates the functions of miR-377-5p in cervical cancer

MicroRNA-543 Acts As a Prognostic Marker and Promotes the Cell Proliferation in Cervical Cancer by BRCA1-interacting Protein 1.

MicroRNA-153 acts as a prognostic marker in gastric cancer and its role in cell migration and invasion.

Mir-141-5p Affects the Cell Proliferation and Apoptosis by Targeting BTG1 in Cervical Cancer

Mir-195 Inhibits the Proliferation of Human Cervical Cancer Cells by Directly Targeting Cyclin D1

Preserved Mir-361-3p Expression is an Independent Prognostic Indicator of Favorable Survival in Cervical Cancer